Kloiber S

Department of Psychiatry, University of Toronto, Toronto, ON, Canada. stefan.kloiber@camh.ca.

3 papers · ORCID

ArticlePsilocybin

Psilocybin as an emerging anxiolytic: mechanisms, evidence, and open questions.

Konstantinou GN, Kloiber S

Europe PMC2026
ArticlePsilocybin

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.

Husain MI, Blumberger DM, Castle DJ +8

Europe PMC2023
ArticlePsilocybin

A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocol

Husain M, Blumberger D, Castle D +4

Europe PMC2023